[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Invivyd Inc (IVVD)

Invivyd Inc (IVVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Invivyd Inc 209 CHURCH STREET NEW HAVEN CT 06510 USA

https://invivyd.com Employees: 122 P: 781-819-0080

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 285,739
Enterprise Value, $K 59,049
Shares Outstanding, K 294,607
Float, K 258,518
% Float 87.75%
Short Interest, K 30,933
Short Float 10.50%
Days to Cover 10.64
Short Volume Ratio 0.40
% of Insider Shareholders 12.25%
% of Institutional Shareholders 70.36%

Financials:

Annual Sales, $ 53,430 K
Annual Net Income, $ -52,490 K
Last Quarter Sales, $ 13,740 K
Last Quarter Net Income, $ -41,400 K
EBIT, $ -81,780 K
EBITDA, $ -79,670 K

Growth:

1-Year Return 22.59%
3-Year Return -12.91%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 05/14/26
Next Earnings Date 08/13/26
Earnings Per Share ttm -0.31
EPS Growth vs. Prev Year 7.14%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IVVD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -53.48%
Return-on-Assets % -41.56%
Profit Margin % -98.24%
Debt/Equity 0.00
Price/Sales 5.13
Price/Cash Flow N/A
Price/Book 1.35
Book Value/Share 0.72
Interest Coverage -0.22
60-Month Beta 0.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.